| Crude suicide rates (per 100 000 population) WHO | WHO | – |
| Age-standardized suicide rates (per 100 000 population) WHO | WHO | +1.4% |
| Mortality rate attributed to unintentional poisoning (per 100 000 population) WHO | WHO | −33.3% |
| Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths WHO | WHO | +19.4% |
| Age-standardized NCD mortality rate (per 100 000 population) WHO | WHO | −20.2% |
| Total NCD Deaths WHO | WHO | −23.1% |
| Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease WHO | WHO | −0.8% |
| Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) WHO | WHO | +2.2% |
| Number of female leprosy new cases WHO | WHO | +100% |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population WHO | WHO | 0 |
| Number of non-autochthonous leprosy cases WHO | WHO | +8.3% |
| New leprosy case detection rate per 1 000 000 population WHO | WHO | +7.5% |
| Leprosy - Number of cases registered for treatment WHO | WHO | +25% |
| Leprosy registered prevalence rate per 1 000 000 population WHO | WHO | +24.1% |
| Number of new G2D leprosy cases WHO | WHO | +100% |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population WHO | WHO | +100% |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases with G2D among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases WHO | WHO | +8.3% |
| New chronic hepatitis B (HBV) infections (number) WHO | WHO | – |
| Hepatitis - Deaths caused by chronic hepatitis B and C (per 100 000 population) WHO | WHO | – |
| People living with chronic hepatitis B (HBV) (number) WHO | WHO | – |
| Prevalence of chronic hepatitis B (HBV) in the general population (%) WHO | WHO | – |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | +13.1% |
| People living with chronic hepatitis C (HCV) (number) WHO | WHO | – |
| Prevalence of chronic hepatitis C (HCV) ) in the general population (%) WHO | WHO | – |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | – |
| Persons on chronic hepatitis C (HCV) treatment, cumulative (number) WHO | WHO | – |
| Chronic hepatitis C (HCV) cumulative treatment rate as percentage of total infected, including cured (%) WHO | WHO | – |
| Persons initiated chronic hepatitis C(HCV) treatment (number) WHO | WHO | – |
| Chronic hepatitis B (HBV) infected persons diagnosed (number) WHO | WHO | – |
| Chronic hepatitis B (HBV) diagnosis coverage as a percentage of infected (%) WHO | WHO | – |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | −45.5% |
| Pregnant women attending antenatal care, tested for HBsAg (percent) WHO | WHO | – |
| Pregnant women attending antenatal care, tested positive for HBsAg (percent) WHO | WHO | – |
| Eligible women attending antenatal care who were treated for HBV WHO | WHO | – |
| Life expectancy at birth (years) WHO | WHO | +2.1% |
| Healthy life expectancy (HALE) at birth (years) WHO | WHO | +1.6% |
| Healthy life expectancy (HALE) at age 60 (years) WHO | WHO | +7.1% |
| Life expectancy at age 60 (years) WHO | WHO | +7.2% |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) WHO | WHO | −3.6% |
| Physical activity policies for activie societies WHO | WHO | 0% |
| Physical activity policies focused on active systems WHO | WHO | 0% |
| Number of imported cases of visceral leishmaniasis reported WHO | WHO | +2 |
| Proportion of cities, municipalities and localities in regional Healthy City networks that are health-promoting WHO | WHO | – |
| Overweight numbers among children under 5 years of age (thousands), model-based estimates WHO | WHO | −1.8% |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates WHO | WHO | 0% |
| Stunting numbers among children under 5 years of age (millions), model-based estimates WHO | WHO | +1.9% |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates WHO | WHO | +2.6% |
| Health care expenditure by provider Eurostat | Eurostat | +3.8% |
| Revenues of health care financing schemes Eurostat | Eurostat | +6.5% |
| Health care expenditure by function Eurostat | Eurostat | +3.4% |
| Health care expenditure by function Eurostat | Eurostat | −1.4% |
| Health care expenditure by function Eurostat | Eurostat | −2% |
| Expenditure for selected health care functions by health care financing schemes Eurostat | Eurostat | −3.1% |
| Expenditure for selected health care functions by health care providers Eurostat | Eurostat | −2.9% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +6.4% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +3.8% |
| Health care expenditure by financing scheme Eurostat | Eurostat | 0% |
| Revenues of health care financing schemes by health care financing schemes Eurostat | Eurostat | +6.4% |
| Expenditure for selected health care providers by health care financing schemes Eurostat | Eurostat | +3.6% |
| Out-of-pocket expenditure on healthcare Eurostat | Eurostat | −0.1% |
| Total health care expenditure Eurostat | Eurostat | +6.4% |
| Long-term care (health) expenditure Eurostat | Eurostat | +4.9% |
| Number of under-five deaths WHO | WHO | +1.2% |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) WHO | WHO | +2.2% |
| Stillbirth rate (per 1000 total births) WHO | WHO | 0% |
| Number of deaths among children ages 5 to 9 years WHO | WHO | −0.8% |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) WHO | WHO | 0% |
| Number of neonatal deaths WHO | WHO | +2.1% |
| Neonatal mortality rate (per 1000 live births) WHO | WHO | 0% |
| Number of deaths among children 5 to 14 years of age WHO | WHO | +0.3% |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) WHO | WHO | 0% |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) WHO | WHO | +3.8% |
| Number of infant deaths WHO | WHO | +1.5% |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) WHO | WHO | 0% |
| Number of deaths among adolescents (10 to 19 years of age) WHO | WHO | +1.3% |
| Adolescent mortality rate (per 1 000 age specific cohort) WHO | WHO | 0% |
| Hepatitis B surface antigen (HBsAg) prevalence (%) WHO | WHO | +100% |
| Estimated number of people (all ages) living with HIV WHO | WHO | 0% |
| Reported number of people receiving antiretroviral therapy WHO | WHO | +5% |
| Number of new HIV infections WHO | WHO | 0% |
| Estimated antiretroviral therapy coverage among people living with HIV (%) WHO | WHO | +2.3% |
| Prevalence of HIV among adults aged 15 to 49 (%) WHO | WHO | 0% |
| Causes of death - infant mortality by country of occurrence Eurostat | Eurostat | 0 |
| Peri-neonatal mortality by age of mother, by residence and occurrence Eurostat | Eurostat | 0% |
| Fetal, peri- and neonatal mortality rates by country of occurrence Eurostat | Eurostat | +4.8% |
| Deaths related to infectious diseases Eurostat | Eurostat | −0.8% |
| Deaths related to transport accidents occurring in the country Eurostat | Eurostat | 0% |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) WHO | WHO | – |
| Acute care OECD | OECD | −15.5% |
| Cancer care OECD | OECD | +2.2% |
| End-of-life care OECD | OECD | −2.6% |
| Healthcare quality and outcomes OECD | OECD | −2.6% |
| Integrated care OECD | OECD | +19.6% |
| Mental healthcare OECD | OECD | +200% |
| Primary care OECD | OECD | +26.8% |
| Patient experiences OECD | OECD | +520% |
| Prescribing in primary care OECD | OECD | +15.6% |
| Patient safety OECD | OECD | +5.3% |
| Self-reported unmet needs for medical examination by sex, age, main reason declared and income quintile Eurostat | Eurostat | −1.8 |
| Level of disability (activity limitation) by sex, age and degree of urbanisation Eurostat | Eurostat | +4.9% |
| Level of disability (activity limitation) by sex, age and country of birth Eurostat | Eurostat | – |
| Level of disability (activity limitation) by sex, age and country of birth Eurostat | Eurostat | +101.6% |
| Level of disability (activity limitation) by sex, age and citizenship Eurostat | Eurostat | – |
| Level of disability (activity limitation) by sex, age and citizenship Eurostat | Eurostat | +63.6% |
| Self-reported unmet need for medical examination and care by sex Eurostat | Eurostat | +37.8% |
| Self-reported unmet need for medical care by sex Eurostat | Eurostat | +37.8% |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | −2.1% |
| Healthy life years by sex (from 2004 onwards) Eurostat | Eurostat | −1.9% |
| Healthy life years at birth by sex Eurostat | Eurostat | −1.9% |
| Healthy life years at age 65 by sex Eurostat | Eurostat | −4.5% |
| Healthy life years at 65 - males Eurostat | Eurostat | −2.9% |
| Healthy life years at 65 - females Eurostat | Eurostat | −4.5% |
| Healthy life years at birth by sex Eurostat | Eurostat | −1.9% |
| Life expectancy at birth by sex Eurostat | Eurostat | 0% |
| Revenues of healthcare financing schemes OECD | OECD | +3.4% |
| Gross fixed capital formation in the healthcare system OECD | OECD | 0% |
| Deaths by age, sex and legal marital status Eurostat | Eurostat | +2.2% |
| Reported number of human rabies deaths WHO | WHO | 0 |
| Health risks - Regions OECD | OECD | +3.6% |
| HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) WHO | WHO | −2.6% |
| Polio (Pol3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Pertussis - number of reported cases WHO | WHO | −96.7% |
| Total tetanus - number of reported cases WHO | WHO | +60% |
| Yellow fever - number of reported cases WHO | WHO | 0 |
| Rubella - number of reported cases WHO | WHO | 0 |
| Diphtheria - number of reported cases WHO | WHO | +15.4% |
| Japanese encephalitis - number of reported cases WHO | WHO | 0 |
| Mumps - number of reported cases WHO | WHO | +3.3% |
| Congenital Rubella Syndrome - number of reported cases WHO | WHO | 0 |
| Neonatal tetanus - number of reported cases WHO | WHO | 0 |
| Measles - number of reported cases WHO | WHO | −60.7% |
| Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) WHO | WHO | −1.2% |
| Hib (Hib3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Inpatient curative care bed occupancy rate by type of care Eurostat | Eurostat | +0.1% |
| Medical technologies - examinations by medical imaging techniques (CT, MRI and PET) Eurostat | Eurostat | +2.6% |
| Hospital discharges and length of stay for inpatient curative care Eurostat | Eurostat | +2% |
| Surgical procedures Eurostat | Eurostat | +4.5% |
| Consultation of a dentist per inhabitant Eurostat | Eurostat | −8% |
| Vaccination against influenza of population aged 65 and over Eurostat | Eurostat | +0.6% |
| Preventive cancer screenings - programme data Eurostat | Eurostat | −0.2% |
| Hospital beds by hospital ownership Eurostat | Eurostat | +1.8% |
| Available beds in hospitals by NUTS 2 region Eurostat | Eurostat | +1.5% |
| Health graduates Eurostat | Eurostat | +3.1% |
| Health graduates Eurostat | Eurostat | −2.7% |
| Devices for medical imaging Eurostat | Eurostat | – |
| Physicians by sex and age Eurostat | Eurostat | +3.7% |
| Physicians by category Eurostat | Eurostat | +3.1% |
| Health personnel Eurostat | Eurostat | −4.4% |
| Health personnel Eurostat | Eurostat | +1.1% |
| Hospital employment Eurostat | Eurostat | +3.5% |
| Technical resources in hospital Eurostat | Eurostat | +0.1% |
| Health workforce migration Eurostat | Eurostat | +79.6% |
| Self-reported unmet needs for medical examination by main reason declared and NUTS 2 region Eurostat | Eurostat | +100% |
| Avoidable mortality OECD | OECD | −3.8% |
| Sickness absences from work OECD | OECD | −11.1% |
| Cancer OECD | OECD | +8.9% |
| Communicable diseases OECD | OECD | 0% |
| Injuries OECD | OECD | −3.6% |
| Infant health: low birthweight OECD | OECD | +1.4% |
| Life expectancy OECD | OECD | −2.5% |
| Maternal and infant mortality OECD | OECD | −3.3% |
| Perceived health status OECD | OECD | +2.7% |
| Perceived health status by socio-economic status OECD | OECD | −0.5% |
| Potential years of life lost OECD | OECD | +0.2% |
| Adopted written national policy on alcohol WHO | WHO | – |
| Alcoholic beverage legally defined WHO | WHO | – |
| National legislation to prevent illegal alcohol WHO | WHO | 0 |
| Standard drink defined WHO | WHO | −87.5% |
| National legislation to prevent illegal alcohol sales WHO | WHO | 0% |
| Hospital aggregates OECD | OECD | +3.5% |
| Consultations OECD | OECD | −15.3% |
| Diagnostic exams OECD | OECD | +7.8% |
| Hospital average length of stay by diagnostic categories OECD | OECD | −2.7% |
| Hospital discharges by diagnostic categories OECD | OECD | +1.1% |
| Immunisations OECD | OECD | +0.1% |
| Screening OECD | OECD | +0.1% |
| Surgical procedures OECD | OECD | +25% |
| Waiting times OECD | OECD | −8.5% |
| Remuneration of health professionals OECD | OECD | 0% |
| Generic market OECD | OECD | −5% |
| Pharmaceutical market OECD | OECD | +6.2% |
| Pharmaceutical consumption OECD | OECD | +6.2% |
| Pharmaceutical sales OECD | OECD | +6.9% |
| Healthcare coverage OECD | OECD | +1.5% |
| Risk factors for health OECD | OECD | −5.4% |
| Alcohol consumption OECD | OECD | −5.4% |
| Body weight OECD | OECD | −0.3% |
| Food supply and consumption OECD | OECD | +2.9% |
| Tobacco consumption OECD | OECD | −16% |
| Use of vaping products OECD | OECD | −10.8% |
| Self-perceived health by sex, age and degree of urbanisation Eurostat | Eurostat | – |
| People having a long-standing illness or health problem, by sex, age and degree of urbanisation Eurostat | Eurostat | +6.9% |
| Self-reported unmet needs for medical examination by sex, age, main reason declared and degree of urbanisation Eurostat | Eurostat | +0.2 |
| Self-reported unmet needs for dental examination by sex, age, main reason declared and degree of urbanisation Eurostat | Eurostat | +2.3 |
| Distribution of population aged 18 and over by health status, age group, sex and degree of urbanisation Eurostat | Eurostat | −5.7% |
| Government monopoly on production WHO | WHO | 0 |
| Government monopoly on retail sales WHO | WHO | 0 |
| Detection of marketing infringements WHO | WHO | 0% |
| Penalties for marketing infringements WHO | WHO | 0% |
| Off-premise sales restrictions on days WHO | WHO | 0 |
| Off-premise sales restrictions on hours WHO | WHO | 0 |
| Off-premise sales restrictions on places WHO | WHO | 0 |
| Off-premise sales restrictions on outlet density WHO | WHO | 0 |
| On-premise sales restrictions on days WHO | WHO | 0 |
| On-premise sales restrictions on hours WHO | WHO | 0 |
| On-premise sales restrictions on places WHO | WHO | 0 |
| On-premise sales restrictions on outlet density WHO | WHO | 0 |
| On-premise sales restrictions to intoxicated persons WHO | WHO | – |
| Server training WHO | WHO | – |
| Remote ordering of alcohol regulated WHO | WHO | – |
| Level of taxation adjusted for inflation WHO | WHO | −1 |
| Duty paid or excise stamp on alcohol container WHO | WHO | +1 |
| Number of standard alcoholic drinks displayed on containers WHO | WHO | 0 |
| Alcohol content displayed on containers WHO | WHO | 0% |
| Health warning labels on pregnancy WHO | WHO | 0 |
| Health warning labels on under-age drinking WHO | WHO | 0 |
| Health warning labels on drink-driving WHO | WHO | 0 |
| Health warning labels on alcohol advertising WHO | WHO | 0 |
| Health warning labels on alcohol containers WHO | WHO | 0 |
| Legal blood alcohol concentration (BAC) limits WHO | WHO | – |
| Age limits off-premise sales WHO | WHO | 0% |
| Random breath testing (RBT) use WHO | WHO | −1 |
| Penalties for drink driving WHO | WHO | 0 |
| Sobriety checkpoints WHO | WHO | 0 |
| Graduated licensing WHO | WHO | 0 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type WHO | WHO | −5.9% |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | 0% |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | 0% |
| Alcohol, tourist consumption (in litres of pure alcohol), three-year average WHO | WHO | 0% |
| Alcohol, consumption of pure alcohol by type of beverage (%) WHO | WHO | 0% |
| Health workforce migration OECD | OECD | 0 |
| Long-term care resources and utilisation - beds OECD | OECD | 0% |
| Long-term care resources and utilisation - recipients OECD | OECD | +0.1% |
| Cancer survival for those diagnosed with breast cancer, 5-year net survival (%) WHO | WHO | – |
| Number of imported cases of cutaneous leishmaniasis reported WHO | WHO | −15 |
| Obesity rate by body mass index (BMI) Eurostat | Eurostat | −1.1% |
| Healthy life years by sex (from 2004 onwards) Eurostat | Eurostat | −1.9% |
| Healthy life years by sex (from 2004 onwards) Eurostat | Eurostat | −2.3% |
| Healthy life expectancy based on self-perceived health Eurostat | Eurostat | −0.7% |
| Household air pollution attributable deaths WHO | WHO | – |
| Household air pollution attributable DALYs WHO | WHO | – |
| Household air pollution attributable DALYs (per 100 000, age-standardized) WHO | WHO | – |
| Household air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Ambient air pollution attributable deaths WHO | WHO | – |
| Ambient air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Ambient air pollution attributable DALYs WHO | WHO | – |
| Ambient air pollution attributable DALYs (per 100 000 population, age-standardized) WHO | WHO | – |
| Joint effects of air pollution attributable deaths WHO | WHO | – |
| Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized) WHO | WHO | – |
| Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2), three-year average WHO | WHO | 0% |
| Low birth weight number (in thousands) WHO | WHO | −4.7% |
| Low birth weight prevalence (%) WHO | WHO | −1.4% |
| Causes of death - years and potential years of life lost by NUTS 2 region of residence, 3 year average Eurostat | Eurostat | +1.9% |
| Self-perceived health by sex, age and educational attainment level Eurostat | Eurostat | +150% |
| Self-perceived health by sex, age and educational attainment level Eurostat | Eurostat | −7.5% |
| Self-perceived health by sex, age and income quintile Eurostat | Eurostat | +113.3% |
| Self-perceived health by sex, age and income quintile Eurostat | Eurostat | +72.7% |
| Self-perceived health by sex, age and income quintile Eurostat | Eurostat | −10.2% |
| Self-perceived health by sex, age and income quintile Eurostat | Eurostat | +5.5% |
| People having a long-standing illness or health problem, by sex, age and income quintile Eurostat | Eurostat | +5.4% |
| Level of disability (activity limitation) by sex, age and income quintile Eurostat | Eurostat | −2.4% |
| Persons with financial burden of health care by level of difficulty, type of health care, household composition and risk of poverty threshold Eurostat | Eurostat | – |
| Persons with financial burden of health care by level of difficulty, type of health care, degree of urbanization and income quantile Eurostat | Eurostat | – |
| Persons visiting a doctor in the last 12 months by medical speciality, number of visits, educational attainment level, sex and age Eurostat | Eurostat | – |
| Persons visiting a doctor in the last 12 months by medical speciality, frequency, most frequent activity status, degree of urbanization and income quantile Eurostat | Eurostat | – |
| Person distribution by body mass index, educational attainment level, sex and age Eurostat | Eurostat | – |
| Persons eating fruit, vegetables or salad by educational attainment level, risk of poverty threshold, most frequent activity status and sex Eurostat | Eurostat | – |
| Share of people with good or very good perceived health by sex Eurostat | Eurostat | −1.4% |
| Standardised death rate due to tuberculosis, HIV and hepatitis by type of disease Eurostat | Eurostat | −9.1% |
| Death due to cancer, by sex Eurostat | Eurostat | −2% |
| Death due to other ischaemic heart diseases, by sex Eurostat | Eurostat | −9.2% |
| Death due to suicide, by sex Eurostat | Eurostat | +14.8% |
| Death due to accidents, by sex Eurostat | Eurostat | +3.9% |
| Death due to pneumonia, by sex Eurostat | Eurostat | −1.2% |
| Death due to chronic liver disease, by sex Eurostat | Eurostat | −6.1% |
| Death due to diseases of the nervous system, by sex Eurostat | Eurostat | +4.5% |
| Death due to diabetes mellitus, by sex Eurostat | Eurostat | −1.2% |
| Death due to alcoholic abuse, by sex Eurostat | Eurostat | +5.6% |
| Death due to AIDS (HIV-disease), by sex Eurostat | Eurostat | +33.3% |
| Death due to drugs dependence, by sex Eurostat | Eurostat | −14.3% |
| Causes of death, by sex Eurostat | Eurostat | −0.6% |
| Suicide death rate by age group Eurostat | Eurostat | +12.2% |
| Life expectancy at birth by sex Eurostat | Eurostat | 0% |
| Late foetal deaths by mother's age Eurostat | Eurostat | −6.5% |
| Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) (%) WHO | WHO | 0% |
| Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) (%) WHO | WHO | 0% |
| Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) (%) WHO | WHO | 0% |
| Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) (%) WHO | WHO | +0.2% |
| Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) (%) WHO | WHO | +0.7% |
| Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) (%) WHO | WHO | +1% |